{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:31:52Z","timestamp":1779222712099,"version":"3.51.4"},"reference-count":82,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2014.00251","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T13:41:29Z","timestamp":1411998089000},"source":"Crossref","is-referenced-by-count":15,"title":["Hidden Treasures in \u00e2\u20ac\u0153Ancient\u00e2\u20ac\u009d Microarrays: Gene-Expression Portrays Biology and Potential Resistance Pathways of Major Lung Cancer Subtypes and Normal Tissue"],"prefix":"10.3389","volume":"4","author":[{"given":"Konstantinos","family":"Kerkentzes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Lagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Tsamardinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mogens","family":"Vyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluf Dimitri","family":"R\u00c3\u00b8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1378\/chest.12-2345","article-title":"Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Alberg","year":"2013","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4329\/wjr.v4.i4.128","article-title":"The 7th lung cancer TNM classification and staging system: review of the changes and implications","volume":"4","author":"Mirsadraee","year":"2012","journal-title":"World J Radiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","article-title":"New pathologic classification of lung cancer: relevance for clinical practice and clinical trials","volume":"31","author":"Travis","year":"2013","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/annonc\/mdr563","article-title":"Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer","volume":"23","author":"Smit","year":"2012","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrclinonc.2009.223","article-title":"Chemotherapy: continued lack of progress in SCLC","volume":"7","author":"Subramanian","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1073\/pnas.191502998","article-title":"Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses","volume":"98","author":"Bhattacharjee","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e6554","DOI":"10.1371\/journal.pone.0006554","article-title":"Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype","volume":"4","author":"R\u00c3\u00b8e","year":"2009","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy \u00e2\u20ac\u201c analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recognit Lett"},{"key":"B13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/bioinformatics\/btl567","article-title":"Using GOstats to test gene lists for GO term association","volume":"23","author":"Falcon","year":"2007","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey","year":"2002","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/bioinformatics\/btq261","article-title":"Structure-based variable selection for survival data","volume":"26","author":"Lagani","year":"2010","journal-title":"Bioinformatics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/bioinformatics\/bti033","article-title":"A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis","volume":"21","author":"Statnikov","year":"2005","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/nar\/gki188","article-title":"Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays","volume":"33","author":"Yap","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e10312","DOI":"10.1371\/journal.pone.0010312","article-title":"Gene expression-based classification of non-small cell lung carcinomas and survival prediction","volume":"5","author":"Hou","year":"2010","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/bioinformatics\/btl385","article-title":"OrderedList \u00e2\u20ac\u201c a bioconductor package for detecting similarity in ordered gene lists","volume":"22","author":"Lottaz","year":"2006","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19990915\/30)18:17\/182529::AID-SIM2743.0.CO;2-5","article-title":"Assessment and comparison of prognostic classification schemes for survival data","volume":"18","author":"Graf","year":"1999","journal-title":"Stat Med"},{"issue":"23","key":"B21","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1200\/JCO.2012.47.1102","article-title":"PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer","volume":"31","author":"Paz-Ares","year":"2013","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e59314","DOI":"10.1371\/journal.pone.0059314","article-title":"Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","volume":"368","author":"Shaw","year":"2013","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/modpathol.2011.173","article-title":"p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma","volume":"25","author":"Bishop","year":"2012","journal-title":"Mod Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1309\/AJCP50RDXSCSBTBO","article-title":"Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study","volume":"140","author":"Brunnstr\u00c3\u00b6m","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1043\/1543-2165(2008)132","article-title":"Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung","volume":"132","author":"Jagirdar","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/PAI.0b013e31825439bc","article-title":"Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update","volume":"20","author":"Ord\u00c3\u00b3\u00c3\u00b1ez","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/PAI.0b013e318251d8c1","article-title":"Thyroid transcription factor-1 is not expressed in squamous cell carcinomas of the lung: an immunohistochemical study with review of the literature","volume":"20","author":"Ord\u00c3\u00b3\u00c3\u00b1ez","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/modpathol.2011.92","article-title":"Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens","volume":"24","author":"Rekhtman","year":"2011","journal-title":"Mod Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/modpathol.2009.60","article-title":"A novel five-antibody immunohistochemical test for subclassification of lung carcinoma","volume":"22","author":"Ring","year":"2009","journal-title":"Mod Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nmeth.2630","article-title":"ExpressionBlast: mining large, unstructured expression databases","volume":"10","author":"Zinman","year":"2013","journal-title":"Nat Methods"},{"key":"B32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cllc.2011.10.003","article-title":"The role of cyclin D1 expression and patient\u00e2\u20ac\u2122s survival in non-small-cell lung cancer: a systematic review with meta-analysis","volume":"13","author":"Zhang","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1479-5876-8-86","article-title":"Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer","volume":"8","author":"Castro","year":"2010","journal-title":"J Transl Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00200658","article-title":"Immunohistochemistry of cyclin D3 in pulmonary carcinomas","volume":"428","author":"Usuda","year":"1996","journal-title":"Virchows Arch"},{"key":"B35","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/gcc.20904","article-title":"Hypomethylation of the 14-3-3 sigma promoter leads to increased expression in non-small cell lung cancer","volume":"50","author":"Radhakrishnan","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"B36","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1074\/mcp.R800013-MCP200","article-title":"A gene-centric human protein atlas for expression profiles based on antibodies","volume":"7","author":"Berglund","year":"2008","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"B37","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1093\/carcin\/bgt271","article-title":"An exploration of pathways involved in lung carcinoid progression using gene expression profiling","volume":"34","author":"Swarts","year":"2013","journal-title":"Carcinogenesis"},{"key":"B38","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1158\/1078-0432.1294.11.3","article-title":"Loss of reduced folate carrier function and folate depletion result in enhanced pemetrexed inhibition of purine synthesis","volume":"11","author":"Zhao","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B39","first-page":"68","article-title":"Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs","volume":"26","author":"Schultz","year":"1999","journal-title":"Semin Oncol"},{"key":"B40","first-page":"3675","article-title":"Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors","volume":"61","author":"van derWilt","year":"2001","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e74284","DOI":"10.1371\/journal.pone.0074284","article-title":"Association between TYMS expression and efficacy of pemetrexed-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.lungcan.2008.04.003","article-title":"A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer","volume":"63","author":"Gr\u00c3\u00b8nberg","year":"2009","journal-title":"Lung Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1200\/JCO.2009.23.1548","article-title":"Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer","volume":"27","author":"Socinski","year":"2009","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","article-title":"Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin","volume":"17","author":"Zucali","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/JTO.0b013e3181e0b954","article-title":"Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells","volume":"5","author":"Wu","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.bjc.6603910","article-title":"Targeting HER proteins in cancer therapy and the role of the non-target HER3","volume":"97","author":"Hsieh","year":"2007","journal-title":"Br J Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1200\/JCO.2009.23.1431","article-title":"Genetic abnormalities of the EGFR pathway in African American patients with non-small-cell lung cancer","volume":"27","author":"Leidner","year":"2009","journal-title":"J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1200\/JCO.2012.45.6095","article-title":"Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives","volume":"31","author":"Mazi\u00c3\u00a8res","year":"2013","journal-title":"J Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1200\/JCO.2012.44.2806","article-title":"Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations","volume":"31","author":"Sequist","year":"2013","journal-title":"J Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1158\/1078-0432.CCR-08-2549","article-title":"Analysis of ErbB receptors in pulmonary carcinoid tumors","volume":"15","author":"Rickman","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"Suppl 2","key":"B52","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S0169-5002(07)70422-1","article-title":"Improving patient management in metastatic non-small cell lung cancer","volume":"57","author":"Vansteenkiste","year":"2007","journal-title":"Lung Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1158\/1078-0432.CCR-11-2863","article-title":"Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer","volume":"18","author":"Wang","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/annonc\/mdr624","article-title":"Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses","volume":"23","author":"Pierceall","year":"2012","journal-title":"Ann Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.lungcan.2009.03.016","article-title":"Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets","volume":"67","author":"R\u00c3\u00b8e","year":"2010","journal-title":"Lung Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.1192656","article-title":"FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair","volume":"329","author":"Liu","year":"2010","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1158\/1535-7163.MCT-05-0493","article-title":"Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway","volume":"5","author":"Chirnomas","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1158\/0008-5472.CAN-11-0080","article-title":"Two novel determinants of etoposide resistance in small cell lung cancer","volume":"71","author":"Lawson","year":"2011","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1073\/pnas.90.9.4166","article-title":"Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas","volume":"90","author":"Schweinfest","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60","first-page":"1857","article-title":"Down-regulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression","volume":"4","author":"Antalis","year":"1998","journal-title":"Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ctrv.2012.06.001","article-title":"Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer","volume":"39","author":"Fang","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1073\/pnas.0308525100","article-title":"Rho activity critically and selectively regulates endothelial cell organization during angiogenesis","volume":"101","author":"Hoang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1097\/00004872-199816121-00011","article-title":"Mechanical influences on vascular smooth muscle cell function","volume":"16","author":"Williams","year":"1998","journal-title":"J Hypertens"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1101\/gad.535409","article-title":"Integrin-linked kinase controls vascular wall formation by negatively regulating Rho\/ROCK-mediated vascular smooth muscle cell contraction","volume":"23","author":"Kogata","year":"2009","journal-title":"Genes Dev"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e30880","DOI":"10.1371\/journal.pone.0030880","article-title":"Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e40521","DOI":"10.1371\/journal.pone.0040521","article-title":"Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma","volume":"7","author":"R\u00c3\u00b8e","year":"2012","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ymthe.2005.12.009","article-title":"Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus","volume":"13","author":"Gao","year":"2006","journal-title":"Mol Ther"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1158\/1078-0432.CCR-06-1730","article-title":"Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer","volume":"13","author":"Gery","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1083\/jcb.200408130","article-title":"Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis","volume":"167","author":"Weis","year":"2004","journal-title":"J Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/jnci\/djn176","article-title":"CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas","volume":"100","author":"Fujita","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"B71","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.febslet.2009.05.007","article-title":"IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis","volume":"583","author":"White","year":"2009","journal-title":"FEBS Lett"},{"key":"B73","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.bbadis.2012.02.019","article-title":"IQGAP2, a candidate tumour suppressor of prostate tumorigenesis","volume":"1822","author":"Xie","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cm.21150","article-title":"Microtubules and actin work together to polarize cells for division and migration","volume":"71","author":"Akhshi","year":"2013","journal-title":"Cytoskeleton (Hoboken)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-12-4142","article-title":"Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability","volume":"73","author":"Belaid","year":"2013","journal-title":"Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/en.2008-1165","article-title":"Roles of testicular orphan nuclear receptors 2 and 4 in early embryonic development and embryonic stem cells","volume":"150","author":"Shyr","year":"2009","journal-title":"Endocrinology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e7830","DOI":"10.1371\/journal.pone.0007830","article-title":"Filamins regulate cell spreading and initiation of cell migration","volume":"4","author":"Baldassarre","year":"2009","journal-title":"PLoS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.chembiol.2013.03.018","article-title":"Pathway databases: making chemical and biological sense of the genomic data flood","volume":"20","author":"D\u00e2\u20ac\u2122Eustachio","year":"2013","journal-title":"Chem Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-1-62703-450-0_14","article-title":"Building models using reactome pathways as templates","volume":"1021","author":"Croft","year":"2013","journal-title":"Methods Mol Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T21:46:04Z","timestamp":1689543964000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2014.00251\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,29]]},"references-count":82,"URL":"https:\/\/doi.org\/10.3389\/fonc.2014.00251","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,29]]}}}